Stock Events

Stock Events

Mountain Valley MD 

$0.047100
14
-$0.01-14.52%Thursday 20:00

Statistics

Day High
0.0501
Day Low
0.0471
52W High
0.0887
52W Low
0.0074
Volume
37,000
Avg. Volume
55,805
Mkt Cap
21.52M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Feb 23Expected
Q2 2016
Q3 2016
Q4 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
-0.0074

Financials

-4,287.69%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
47,281.69Revenue
-2.03MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.36B
CRISPR Therapeutics is involved in gene editing, a cutting-edge area of medicine that could overlap with Mountain Valley MD's work in advanced health technologies.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals engages in creating new therapies for treating cystic fibrosis and other diseases, competing in the biotech space where innovative treatments are key.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is a biopharmaceutical company that develops medicines in areas of unmet medical needs, similar to Mountain Valley MD's mission to improve global health outcomes.
Moderna
MRNA
Mkt Cap75.86B
Moderna is known for its mRNA technology used in vaccines, which competes with Mountain Valley MD's focus on drug delivery technologies and health solutions.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a large pharmaceutical company with a broad range of products that could compete across several of Mountain Valley MD's target areas, including vaccine technologies.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a diversified healthcare giant that competes with Mountain Valley MD in multiple areas, including pharmaceuticals and wellness products.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie operates in the pharmaceutical industry, focusing on innovative therapies, which puts it in competition with Mountain Valley MD's health technology advancements.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotech firm that develops novel therapeutics, potentially competing with Mountain Valley MD's proprietary technology and health solutions.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb is a global biopharmaceutical company that develops drugs in several therapeutic areas, competing with Mountain Valley MD's approach to health and wellness.

About

Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., is a company focused on the health and wellness industry. The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors. Its portfolio includes Quicksome, an advanced oral drug formulation and delivery system; Quicksol, a technology designed to improve solubility; and a dose-sparing adjuvant. Currently, the company is also progressing with the development of IM032, a treatment being tested in male beagle dogs to assess the differences between intramuscular and subcutaneous administration routes. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Show More
CEO
Dennis Hancock
Employees
1
Country
Canada
ISIN
CA62430M1014
WKN
000A42J37

Listings

CN
CA
MLCO.CN
F
DE
20M.F
OTC Link
US
TMLCF
MU
DE
20MP.MU

0 Comments

Share your thoughts

FAQs

What is Mountain Valley MD stock price today?▼
The current price of MVMDF is $0.05 USD — it has decreased by -14.52% in the past 24 hours. Watch Mountain Valley MD stock price performance more closely on the chart.
What is Mountain Valley MD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Mountain Valley MD stocks are traded under the ticker MVMDF.
What is Mountain Valley MD market cap?▼
Today Mountain Valley MD has the market capitalization of 21.52M
What were Mountain Valley MD earnings last quarter?▼
MVMDF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mountain Valley MD revenue for the last year?▼
Mountain Valley MD revenue for the last year amounts to 47,281.69 USD.
What is Mountain Valley MD net income for the last year?▼
MVMDF net income for the last year is -2.03M USD.
How many employees does Mountain Valley MD have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Mountain Valley MD located?▼
Mountain Valley MD operates in the Health & Wellness sector.
When did Mountain Valley MD complete a stock split?▼
The last stock split for Mountain Valley MD was on March 2, 2020 with a ratio of 1:8.
Where is Mountain Valley MD headquartered?▼
Mountain Valley MD is headquartered in Concord, Canada.